Introduction: Migraine and vasovagal syncope are comorbid conditions that may share part of their pathophysiology through autonomic control of the systemic circulation. Nitroglycerin can trigger both syncope and migraine attacks, suggesting enhanced systemic sensitivity in migraine. We aimed to determine the cardiovascular responses to nitroglycerin in migraine.
Methods: In 16 women with migraine without aura and 10 age- and gender-matched controls without headache, intravenous nitroglycerin (0.5 µg·kg·min) was administered. Finger photoplethysmography continuously assessed cardiovascular parameters (mean arterial pressure, heart rate, cardiac output, stroke volume and total peripheral resistance) before, during and after nitroglycerin infusion.
Results: Nitroglycerin provoked a migraine-like attack in 13/16 (81.2%) migraineurs but not in controls ( = .0001). No syncope was provoked. Migraineurs who later developed a migraine-like attack showed different responses in all parameters vs. controls (all < .001): The decreases in cardiac output and stroke volume were more rapid and longer lasting, heart rate increased, mean arterial pressure and total peripheral resistance were higher and decreased steeply after an initial increase.
Discussion: Migraineurs who developed a migraine-like attack in response to nitroglycerin showed stronger systemic cardiovascular responses compared to non-headache controls. The stronger systemic cardiovascular responses in migraine suggest increased systemic sensitivity to vasodilators, possibly due to insufficient autonomic compensatory mechanisms.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066481 | PMC |
| http://dx.doi.org/10.1177/0333102419881657 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Field-testing the explicit diagnostic criteria for transient ischemic attack: a diagnostic accuracy study.
J Neurol
December 2024
Department of Neurology, Inselspital, University Hospital Bern, University of Bern, Freiburgstrasse, 3010, Bern, Switzerland.
Background And Aim: Explicit diagnostic criteria for transient ischemic attack (TIA) (EDCT) have been recently proposed based on the assumption, that a migraine aura-like symptom is not typical for a TIA. However, migraine-like symptoms have been unexpectedly frequent in patients with confirmed ischemic stroke. This cross-sectional study aimed to field-test the EDCT to distinguish transient neurological symptoms caused by cerebral infarction from those caused by migraine aura.
View Article and Find Full Text PDFGlucocorticoid signaling mediates stress-induced migraine-like behaviors in a preclinical mouse model.
Cephalalgia
August 2024
Department of Neuroscience, School of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, TX, USA.
Background: Stress is one of the most common precipitating factors in migraine and is identified as a trigger in nearly 70% of patients. Responses to stress include release of glucocorticoids as an adaptive mechanism, but this may also contribute to migraine attacks. Here, we investigated the role of glucocorticoids on stress-induced migraine-like behaviors.
View Article and Find Full Text PDFBrain-wide mapping of c-Fos expression in nitroglycerin-induced models of migraine.
J Headache Pain
August 2024
Medical School of Chinese PLA, Beijing, 100853, China.
Article Synopsis
- Migraine, particularly chronic migraine (CM), is a complex neurological disorder with poorly understood causes, involving activation of specific brain regions like the insula and amygdala in response to pain.
- The study used nitroglycerin (NTG) to create a mouse model of chronic migraine and investigated the effects of a treatment called Olcegepant (OLC) on pain sensitivity and brain activity.
- Results indicated that OLC improved pain thresholds and reduced anxiety-like behaviors in the mice, with whole-brain imaging revealing significant activation in areas like the isocortex, somatomotor, and somatosensory regions, suggesting these as potential targets for future migraine treatments.
Effects of levcromakalim in patients with migraine aura without headache: An experimental study.
Cephalalgia
August 2024
Danish Headache Center, Department of Neurology, Rigshospitalet - Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
Background/hypothesis: Levcromakalim has previously been shown to induce attacks of migraine with aura in certain individuals. In this study, we tested the migraine-inducing effect of levcromakalim in a cohort of participants with migraine aura without headache.
Methods: In a double-blind, randomized, placebo-controlled cross-over study, eight adult participants with migraine with aura received intravenous infusions of levcromakalim and saline.
Paeonol and glycyrrhizic acid in combination ameliorate the recurrent nitroglycerin-induced migraine-like phenotype in rats by regulating the GABBR2/TRPM8/PRKACA/TRPV1 pathway.
J Ethnopharmacol
November 2024
College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; Research Institute of Chinese Medicine Literature, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address:
Article Synopsis
- PAE (Paeonol) and GLY (Glycyrrhizic acid) are key components in a traditional Chinese medicine prescription used for treating chronic migraines, showing significant analgesic and neuroprotective benefits.
- The study aimed to investigate how the combination of PAE and GLY affects migraine-like symptoms in rats and involved various experimental techniques to assess their impact.
- Results indicated that the treatment effectively increased pain threshold and adjusted serotonin levels while modifying gene expression related to the GABAergic pathway, suggesting a mechanism for migraine symptom alleviation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!